This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Acoustic neuroma

Authoring team

An acoustic neuroma is a benign, slow growing neoplasm of the Schwann cells of the eighth cranial nerve (1,2)

  • comprises about 6% of all intracranial tumors (2)
  • lesions are usually located in the internal auditory canal or the cerebellopontine angle causing compression of the vestibular nerve and resulting eventually in deafness. Early diagnosis - and thus a high index of suspicion - is strongly influential to the prognosis (2)
  • continuous growth of the neuroma may compress the brain stem and also increase intracranial pressure (2)
  • in about 40% of patients a defect in the long arm of the 22nd chromosome has been detected (1)
  • acoustic neuromas, particularly bilateral cases, may occur in patients with neurofibromatosis (1)

Reference:

  • (1) Ramnarine Devindra, Whitfield Peter. Management of patients with vestibular schwannoma. ACNR 2005; 5(4) 2.
  • (2) British association of otorhinolaryngologists 2002. Clinical effectiveness guidelines, Acoustic neuroma (vestibular schwannoma)

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.